VANGUARD GROUP INC - LIPELLA PHARMACEUTICALS INC ownership

LIPELLA PHARMACEUTICALS INC's ticker is and the CUSIP is 53630L100. A total of 5 filers reported holding LIPELLA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of LIPELLA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$51,783
-29.9%
34,5200.0%0.00%
Q2 2023$73,873
+2.2%
34,520
-6.9%
0.00%
Q1 2023$72,29437,0740.00%
Other shareholders
LIPELLA PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Tower Research Capital LLC (TRC) 4,920$7,3800.00%
VANGUARD GROUP INC 34,520$51,7830.00%
UBS Group AG 172$2580.00%
WELLS FARGO & COMPANY/MN 28$420.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of LIPELLA PHARMACEUTICALS INC shareholders